FDA NDC Directory · JSON-LD · Markdown

Nelarabine

NDC 70710-1839 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerZydus Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA215037
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsNELARABINE (5 mg/mL)
Marketing started20220624
Package count2

External sources

Source: openFDA. Public-domain (CC0).